The Cancer Genome Atlas (https://cancergenome.nih.gov) data for lung adenocarcinoma revealed that the survival probability of patients with NSCLC, with high UCA1 expression, is unfavorable than those with low UCA1 expression (Fig. 3). The gene discussed is UCA1; the disease is lung adenocarcinoma.